Last modified by Sarantis Dimitriadis on 2023/12/08 13:20
From version 5.6
edited by Sarantis Dimitriadis
on 2022/06/02 10:50
Change comment: There is no comment for this version
To version 10.1
edited by Sarantis Dimitriadis
on 2023/05/30 11:24
Change comment: There is no comment for this version

Summary

Details

Page properties
Content
... ... @@ -7,6 +7,8 @@
7 7  (% class="western" lang="en-GB" style="text-align:justify" %)
8 8  (% lang="en-US" %)End users can be classified to non-professional and professional groups. Typical non-professional and professional end-user groups in health and wellbeing includes the following:
9 9  
10 +:
11 +
10 10  * (((
11 11  (% lang="en-US" %)**Non-professional end users:**
12 12  
... ... @@ -15,6 +15,8 @@
15 15  * (% lang="en-US" %)**Public health and social service clients: **Those who use public services.
16 16  )))
17 17  
20 +:
21 +
18 18  * (((
19 19  (% lang="en-US" %)**Professional end users**
20 20  
... ... @@ -25,9 +25,13 @@
25 25  * (% lang="en-US" %)**Policy and decisions makers:** Those responsible for making policies and decisions at local, regional, national or international level.
26 26  )))
27 27  
32 +:
33 +
28 28  (% class="western" lang="en-GB" %)
29 29  (% lang="en-US" %)**Business-to-Business Customer (B2B):** B2B-customer is an organization that purchases living lab services from a living lab. B2B-customers can be classified to private, public, education/ research, civil society organizations and networks/cluster groups as follows:
30 30  
37 +:
38 +
31 31  * (((
32 32  (% lang="en-US" %)**Private sector organizations: **(business developers and researchers)
33 33  
... ... @@ -42,6 +42,8 @@
42 42  * (% lang="en-US" %)Pharmaceutical companies
43 43  )))
44 44  
53 +:
54 +
45 45  * (((
46 46  (% lang="en-GB" %)
47 47  (% lang="en-US" %)**Public sector organizations:**
... ... @@ -57,6 +57,8 @@
57 57  * (% lang="en-US" %)**Public funder:** Government or other European, national, regional or local public institutions who is providing public funding for a specific living lab living lab research project via call for application process.
58 58  )))
59 59  
70 +:
71 +
60 60  * (((
61 61  (% lang="en-GB" %)
62 62  (% lang="en-US" %)**Education and research organizations:**
... ... @@ -70,6 +70,8 @@
70 70  * (% lang="en-US" %)**Private research organizations** such as technology and innovation centers
71 71  )))
72 72  
85 +:
86 +
73 73  * (((
74 74  (% lang="en-GB" %)
75 75  (% lang="en-US" %)**Civil society organizations:**
... ... @@ -77,6 +77,8 @@
77 77  * (% lang="en-US" %)Non-governmental organizations (NGO) and nonprofit entities operating at international, national, regional or local level.
78 78  )))
79 79  
94 +:
95 +
80 80  * (((
81 81  (% lang="en-GB" %)
82 82  (% lang="en-US" %)**Networks and clusters:**
... ... @@ -85,239 +85,92 @@
85 85  * (% lang="en-US" %)International, national, regional and local networks
86 86  )))
87 87  
104 +:
88 88  
89 89  (% class="western" lang="en-GB" %)
90 -(% lang="en-US" %)Typical approaches to define (%%)non-professional end users (a.k.a. study participants) in health and wellbeing living lab projects are presented in Table .
107 +(% lang="en-US" %)Typical approaches to define (%%)//**non-professional **//end users (a.k.a. study participants) in health and wellbeing living lab projects are presented in the following table .
91 91  
92 -(% cellspacing="0" style="border-collapse:collapse; margin-left:auto; margin-right:auto" %)
93 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:11px; padding:0.04in 0in; text-align:center; vertical-align:middle; width:634px" %)(((
94 -(% class="western" lang="en-GB" style="text-align:center" %)
95 -(% lang="en-US" %)**Age or age group**
96 -)))
97 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:11px; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)(((
98 -(% class="western" lang="en-GB" %)
109 +(% style="margin-left:auto; margin-right:auto; width:1694px" %)
110 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:11px; text-align:center; vertical-align:middle; width:634px" %)**Age groups**
111 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:40px; text-align:justify; vertical-align:middle; width:152px" %)(((
99 99  (% lang="en-US" %)Specific age range
100 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)(((
101 -(% class="western" %)
113 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:40px; text-align:justify; vertical-align:middle; width:152px" %)(((
102 102  
103 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)(((
115 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:40px; text-align:justify; vertical-align:middle; width:152px" %)(((
104 104  (% class="western" %)
105 105  
106 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:152px" %)(((
118 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:40px; text-align:justify; vertical-align:middle; width:152px" %)(((
107 107  (% class="western" %)
108 108  
109 109  )))
110 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:12px; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)(((
122 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Adolescents|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Adults|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Older Adults|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)General Population
123 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Adolescents Health status (disease, disorder or disability)**
124 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)(((
111 111  (% class="western" lang="en-GB" %)
112 -(% lang="en-US" %)Elderly
113 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)(((
126 +(% lang="en-US" %)Healthy
127 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:153px" %)(((
114 114  (% class="western" lang="en-GB" %)
115 -(% lang="en-US" %)Adults
116 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)(((
117 -(% class="western" lang="en-GB" %)
118 -(% lang="en-US" %)Youth
119 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:152px" %)(((
120 -(% class="western" lang="en-GB" %)
121 -(% lang="en-US" %)Children
122 -)))
123 -|(% colspan="4" style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:12px; padding:0in; vertical-align:top; width:634px" %)(((
124 -(% class="western" %)
125 125  
126 -)))
127 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:12px; padding:0.04in 0in; text-align:center; vertical-align:middle; width:634px" %)(((
128 -(% class="western" lang="en-GB" style="text-align:center" %)
129 -(% lang="en-US" %)**Health status**
130 -)))
131 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:12px; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)(((
130 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:153px" %)(((
132 132  (% class="western" lang="en-GB" %)
133 -(% lang="en-US" %)Healthy
134 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)(((
135 -(% class="western" lang="en-GB" %)
136 -(% lang="en-US" %)Patient
137 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)(((
138 -(% class="western" lang="en-GB" %)
139 -(% lang="en-US" %)Rehabilitant
140 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:152px" %)(((
141 -(% class="western" lang="en-GB" %)
142 -(% lang="en-US" %)Recovered/Survivor
143 -)))
144 -|(% colspan="4" style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:12px; padding:0in; vertical-align:top; width:634px" %)(((
145 -(% class="western" %)
146 146  
147 -)))
148 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:12px; padding:0.04in 0in; text-align:center; vertical-align:middle; width:634px" %)(((
149 -(% class="western" lang="en-GB" style="text-align:center" %)
150 -(% lang="en-US" %)**A specific disease, disorder or disability**
151 -)))
152 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
133 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)(((
153 153  (% class="western" lang="en-GB" %)
154 -(% lang="en-US" %)ADHD
155 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
156 -(% class="western" lang="en-GB" %)
157 -(% lang="en-US" %)Dementia
158 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
159 -(% class="western" lang="en-GB" %)
160 -(% lang="en-US" %)Parkinsons’ disease
161 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)(((
162 -(% class="western" lang="en-GB" %)
163 -(% lang="en-US" %)Loneliness and Social Isolation
164 -)))
165 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:11px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
166 -(% class="western" lang="en-GB" %)
167 -(% lang="en-US" %)Autism
168 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
169 -(% class="western" lang="en-GB" %)
170 -(% lang="en-US" %)Down syndrome
171 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
172 -(% class="western" lang="en-GB" %)
173 -(% lang="en-US" %)Physical disability
174 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)(((
175 -(% class="western" lang="en-GB" %)
176 -(% lang="en-US" %)Mental health
177 -)))
178 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
179 -(% class="western" lang="en-GB" %)
180 -(% lang="en-US" %)Cardiovascular disease
181 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
182 -(% class="western" lang="en-GB" %)
183 -(% lang="en-US" %)Idiopathic pulmonary fibrosis (IPF)
184 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
185 -(% class="western" lang="en-GB" %)
186 -(% lang="en-US" %)Sleep apnea/apnea
187 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)(((
188 -(% class="western" lang="en-GB" %)
189 -(% lang="en-US" %)Mild cognitive impairment
190 -)))
191 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
192 -(% class="western" lang="en-GB" %)
193 -(% lang="en-US" %)Chronic Obstructive Pulmonary Disease (COPD)
194 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
195 -(% class="western" lang="en-GB" %)
196 -(% lang="en-US" %)Language disability
197 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
198 -(% class="western" lang="en-GB" %)
199 -(% lang="en-US" %)Substance abuse (drugs, alcohol)
200 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)(((
201 -(% class="western" lang="en-GB" %)
202 -(% lang="en-US" %)Multiple sclerosis
203 -)))
204 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
205 -(% class="western" lang="en-GB" %)
206 -(% lang="en-US" %)Cognitive disorder (mild, major)
207 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
208 -(% class="western" lang="en-GB" %)
209 -(% lang="en-US" %)Intellectual disability/ Learning difficulty/ Mental retardation
210 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
211 -(% class="western" lang="en-GB" %)
212 -(% lang="en-US" %)Trauma patient
213 -
214 -(% class="western" lang="en-GB" %)
215 -(% lang="en-US" %)(e.g., a spinal cord injury)
216 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)(((
217 -(% class="western" lang="en-GB" %)
218 -(% lang="en-US" %)Neurodegenerative diseases
219 -)))
220 -|(% colspan="4" style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:12px; padding:0in; vertical-align:top; width:634px" %)(((
221 -(% class="western" %)
222 222  
223 223  )))
224 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:12px; padding:0.04in 0in; text-align:center; vertical-align:middle; width:634px" %)(((
225 -(% class="western" lang="en-GB" style="text-align:center" %)
226 -(% lang="en-US" %)**Clients of a specific service**
227 -)))
228 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:11px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
137 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Adults Health status (disease, disorder or disability)**
138 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Healthy|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Schizophrenia|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Multiple-Sclerosis|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Parkinson Disease
139 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:152px" %)Post-Stroke Patients with Moving or Linguistic Disability|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Mild Cognitive Impairment|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Sleep Disorders: e.g., Apnea, Hypopnea|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)With Disability
140 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Healthy with Possible Chronic Conditions|(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)
141 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Older Adults Health status (disease, disorder or disability)**
142 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Healthy|(% style="border-color:currentcolor; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Parkinson Disease|(% style="border-color:currentcolor; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Mild Cognitive Impairment|(% style="border-color:currentcolor; height:30px; text-align:justify; vertical-align:middle; width:152px" %)With Disability
143 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Healthy with Possible Chronic Conditions|(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)(((
229 229  (% class="western" lang="en-GB" %)
230 -(% lang="en-US" %)Child welfare
231 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
232 -(% class="western" lang="en-GB" %)
233 -(% lang="en-US" %)Nursing home
234 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
235 -(% class="western" lang="en-GB" %)
236 -(% lang="en-US" %)Employment service
237 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)(((
238 -(% class="western" %)
239 239  
240 -)))
241 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:12px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
146 +)))|(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)(((
242 242  (% class="western" lang="en-GB" %)
243 -(% lang="en-US" %)Early childhood education
244 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
245 -(% class="western" lang="en-GB" %)
246 -(% lang="en-US" %)Home care
247 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
248 -(% class="western" lang="en-GB" %)
249 249  
250 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)(((
149 +)))|(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)(((
251 251  (% class="western" lang="en-GB" %)
252 252  
253 253  )))
254 -|(% colspan="4" style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:12px; padding:0in; vertical-align:top; width:634px" %)(((
255 -(% class="western" %)
256 -
257 -)))
258 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:12px; padding:0.04in 0in; text-align:center; vertical-align:middle; width:634px" %)(((
259 -(% class="western" lang="en-GB" style="text-align:center" %)
260 -(% lang="en-US" %)**Vulnerable groups**
261 -)))
262 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
153 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**General Population Health status (disease, disorder or disability)**
154 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Healthy|(% style="text-align:justify; vertical-align:middle" %)Ipf Patients|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Prostate Cancer|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)(((
263 263  (% class="western" lang="en-GB" %)
264 -(% lang="en-US" %)Minors/Children
265 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
266 -(% class="western" lang="en-GB" %)
267 -(% lang="en-US" %)Single parents with minor children
268 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
269 -(% class="western" lang="en-GB" %)
270 -(% lang="en-US" %)Persons subjected to psychological, physical or sexual violence
271 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)(((
272 -(% class="western" lang="en-GB" %)
273 -(% lang="en-US" %)Substance users
274 -
275 -(% class="western" lang="en-GB" %)
276 -(% lang="en-US" %)(drugs, alcohol)
156 +Down Syndrome
277 277  )))
278 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
158 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:152px" %)Chronical Diseases: e.g., Persons With Chronic Pulmonary (Copd)|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Cardiological Or Other Conditions (Aphasia)|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Breast Cancer Survivors|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)(((
279 279  (% class="western" lang="en-GB" %)
280 -(% lang="en-US" %)Disabled people
281 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
282 -(% class="western" lang="en-GB" %)
283 -(% lang="en-US" %)Victims of trafficking in human beings
284 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
285 -(% class="western" lang="en-GB" %)
286 -(% lang="en-US" %)Ethnic minorities and immigrants
287 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)(((
288 -(% class="western" lang="en-GB" %)
289 -(% lang="en-US" %)Isolated people
160 +
290 290  )))
291 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
292 -(% class="western" lang="en-GB" %)
293 -(% lang="en-US" %)Elderly people
294 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
295 -(% class="western" lang="en-GB" %)
296 -(% lang="en-US" %)Persons with serious illnesses
297 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
298 -(% class="western" lang="en-GB" %)
299 -(% lang="en-US" %)Homeless people
300 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)(((
301 -(% class="western" lang="en-GB" %)
302 -(% lang="en-US" %)Ex-prisoners and people with criminal background
303 -)))
304 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:12px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
305 -(% class="western" lang="en-GB" %)
306 -(% lang="en-US" %)Pregnant women
307 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
308 -(% class="western" lang="en-GB" %)
309 -(% lang="en-US" %)Persons with mental disorders
310 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)(((
311 -(% class="western" lang="en-GB" %)
162 +
163 +
164 +:
165 +:
166 +: (% lang="en-US" %)Typical approaches to define (%%)//**professional **//end users in health and wellbeing living lab projects are presented in the following table .
167 +
168 +(((
169 +(% style="margin-left:auto; margin-right:auto; width:1694px" %)
170 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Informal Caregivers**
171 +|(% style="height:50px; text-align:justify; vertical-align:middle; width:152px" %)Part of adults and citizens' group|(% style="height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="height:50px; text-align:justify; vertical-align:middle; width:152px" %)
172 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Health Care Professionals / Formal Caregivers**
173 +|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Doctors|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Social workers|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Physiotherapists|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Psychologists
174 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Registered nurses|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Practical nurses|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Physicians|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)
175 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Students**
176 +|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Medical|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Engineering|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Computer Science|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Pedagogues
177 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)English Literature|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Nursing|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Physiotherapy|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Social Services
178 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Health Care Management|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)
179 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Organizations**
180 +|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Hospitals|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Nursing homes|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Care homes|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Home care Organizations
181 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Network organizations|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Day care centers|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %) |(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)
182 +
312 312  
313 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)(((
314 -(% class="western" lang="en-GB" %)
315 -
316 316  )))
317 317  
186 +:
318 318  
319 319  (% class="western" lang="en-GB" %)
320 -(% lang="en-US" style="page-break-before:always" %)Living lab research infrastructure end users and B2B-customers (% style="page-break-before:always" %)in health and wellbeing living lab projects are presented in Table .
189 +(% lang="en-US" style="page-break-before:always" %)Living lab research infrastructure end users and B2B-customers (% style="page-break-before:always" %)in health and wellbeing living lab projects are presented in (%%)the table below(% style="page-break-before:always" %) .
321 321  
322 322  |**Researcher expertise**|**Brief use case description**
323 323  |Policy Makers|Studying the impact of new service models or new collaboration models in healthcare, designing or improving policies, gathering requirements for improving health and wellbeing of citizens, co-creation of research methodologies for policy making

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101007990

Copyright © 2021 VITALISE Project